Laymon, Charles

Maturation of the human striatal dopamine system revealed by PET and quantitative MRI

Larsen, B., Olafsson, V., Calabro, F., Laymon, C., Tervo-Clemmens, B., Campbell, E., Minhas, D., Montez, D., Price, J., & Luna, B. (2020) · Nature Communications

Neurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies

Cited by 107

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers

Janelidze, S., Christian, B. T., Price, J., Laymon, C., Schupf, N., Klunk, W. E., Lott, I., Silverman, W., Rosas, H. D., Zaman, S., et al. (2022) · JAMA Neurology

Dementia and Cognitive Impairment ResearchDown syndrome and intellectual disability research

Cited by 60

Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study

Boerwinkle, A. H., Gordon, B. A., Wisch, J., Flores, S., Henson, R. L., Butt, O. H., McKay, N., Chen, C. D., Benzinger, T. L. S., Fagan, A. M., et al. (2023) · The Lancet Neurology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 55

The Alzheimer's Biomarker Consortium–Down Syndrome (ABC‐DS): A 10‐year report

Handen, B. L., Mapstone, M., Hartley, S., Andrews, H., Christian, B., Lee, J. H., Tudorascu, D., Hom, C., Ances, B. M., Zaman, S., et al. (2025) · Alzheimer's & Dementia

Down syndrome and intellectual disability researchDementia and Cognitive Impairment Research

Cited by 29